Human adenosine A2a receptor (A2aAR) gene: Systematic mutation screening in patients with schizophrenia

Journal of Neural Transmission

Volumn 103, Issue 12, 1996, Pages 1447-1455

  Deckert, J ^a,b   Nothen M M ^b   Rietschel, M ^c   Wildenauer, D ^c   Bondy, B ^d   Ertl, M A ^d   Knapp, M ^c   Schofield, P R ^e   Albus, M ^f   Maier, W ^c   Propping, P ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Institute of Human Genetics   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f KLINIKUM MÜNCHEN OST   (Germany)

Author keywords

Adenosine A2a receptor; Association study; Candidate gene; Genetic variation; Schizophrenia; Single strand conformational analysis

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CODING; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROMODULATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; SCREENING TEST; ALLELE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DNA SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; GENOTYPE; METHODOLOGY; MUTATION; PEDIGREE; RANDOMIZED CONTROLLED TRIAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; GENETIC SCREENING; GENOTYPE; HUMANS; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, PURINERGIC P1; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 0030299843     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271259     Document Type: Article

References (22)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised (DSM-III-R). American Psychiatric Association Press, Washington DC
2. Bridges AJ, Moos HW, Szotek DL, Trivedi BK, Bristol JA, Heffner TG, Bruns RF, Downs DA (1987) N6-(2,2-diphenylethyl)-adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem 30: 1709-1711
3. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high resolution PAGE. Am J Hum Genet 48: 137-144
4. Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, Waldo M, Freedman R, Byerley W (1994) Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 54: 72-79
5. 2a receptor gene: relation to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 deleted region. Hum Genet (in press)
6. Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837-844
7. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63: 765-773
8. 2 dopamine receptors in rat striatum. Mol Brain Res 14: 186-195
9. 2 receptor. Mol Brain Res 15: 62-66
10. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad USA 92: 7612-7616
11. 2a adenosine receptor subtype gene: ADORA2A. Biochem Biophys Res Commun 223: 461-467
12. Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G (1989) Selective amplification and cloning of four new members of the G-protein coupled receptor family. Science 244: 569-572
13. Lucas PB, Pickar D, Kelsoe J, Rapaport M, Pato C, Hommer D (1990) Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 28: 35-40
14. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215
15. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879
16. Palmer TM, Stiles GL (1995) Adenosine receptors. Neuropharmacol 34: 683-694
17. 2a adenosine receptor gene. J Neurochem 66: 362-368
18. Propping P, Nöthen MM (1995) Schizophrenia: genetic tools for unraveling the nature of a complex disorder. Proc Natl Acad Sci USA 92: 7607-7608
19. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D, Ott J, Lamacz M, Liang K-Y, Hanfelt J, Ullrich G, DeMarchi N, Ramu E, McHugh PR, Adler L, Thomas M, Carpenter WT, Manschreck T, Gordon CT, Kimberland M, Babb R, Puck J, Childs B (1994) Sequential strategy to identify a susceptibility gene on chromosome 22q12-q13.1, part 1. Am J Med Genet 54: 36-43
20. Sanger F, Nicklen S, Coulsen AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 137-142
21. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, Lichtermann D, Minges J, Bondy B, Ackenheil M, Altmark D, Hasib D, Gur E, Ebstein RP, Wildenauer DB (1995) Potential linkage for schizophrenia on chromosome 22q12-13: a replication study. Am J Med Genet 60: 436-443
22. Vallada HP, Gill M, Sham P, Lim LCC, Nanko S, Asherson P, Murray RM, McGuffin P, Owen M, Collier D (1995) Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet 60: 139-146